These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 31976779)

  • 1. Strategies to prevent adverse outcomes following
    Rauseo AM; Olsen MA; Reske KA; Dubberke ER
    Expert Rev Anti Infect Ther; 2020 Mar; 18(3):203-217. PubMed ID: 31976779
    [No Abstract]   [Full Text] [Related]  

  • 2. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
    Savage TJ; Sandora TJ
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study.
    Stephenson B; Lanzas C; Lenhart S; Ponce E; Bintz J; Dubberke ER; Day J
    BMC Infect Dis; 2020 Oct; 20(1):799. PubMed ID: 33115427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of underlying mechanisms for interpreting relative risk of Clostridioides difficile infection among antibiotic-exposed patients in healthcare facilities.
    Mitchell C; Keegan LT; Le TTT; Khader K; Beams A; Samore MH; Toth DJA
    PLoS One; 2024; 19(8):e0306622. PubMed ID: 39116083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial resistance in
    Imwattana K; Knight DR; Kullin B; Collins DA; Putsathit P; Kiratisin P; Riley TV
    Expert Rev Anti Infect Ther; 2020 Jan; 18(1):17-25. PubMed ID: 31800331
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustained reductions in unnecessary antimicrobial administration and hospital
    Gaffin N; Spellberg B
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):491-493. PubMed ID: 34915961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent
    Tsigrelis C
    Cleve Clin J Med; 2020 Jun; 87(6):347-359. PubMed ID: 32487555
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridium difficile control measures: current and future methods for prevention.
    Mejia-Chew C; Dubberke ER
    Expert Rev Anti Infect Ther; 2018 Feb; 16(2):121-131. PubMed ID: 29353504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Antibiotic Consumption and Incidence of
    Kim B; Kim J; Pai H
    J Korean Med Sci; 2020 Dec; 35(47):e407. PubMed ID: 33289370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting.
    Dantes R; Epson EE; Dominguez SR; Dolan S; Wang F; Hurst A; Parker SK; Johnston H; West K; Anderson L; Rasheed JK; Moulton-Meissner H; Noble-Wang J; Limbago B; Dowell E; Hilden JM; Guh A; Pollack LA; Gould CV
    Am J Infect Control; 2016 Feb; 44(2):138-45. PubMed ID: 26601705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
    Hawes AM; Desai A; Patel PK
    Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Infection due to Clostridium (Clostridioides) difficile.
    Krishna A; Chopra T
    Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial stewardship program achieved marked decrease in Clostridium difficile infections in a Veterans Hospital.
    Morgan F; Belal M; Lisa B; Ford F; LeMaitre B; Psevdos G
    Am J Infect Control; 2020 Sep; 48(9):1119-1121. PubMed ID: 32035688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare associated
    Šuljagić V; Milenković B; Perić A; Jovanović D; Begović-Kuprešanin V; Starčević S; Tomić A; Vezmar Kovačević S; Dragojević-Simić V
    Libyan J Med; 2020 Dec; 15(1):1708639. PubMed ID: 31905110
    [No Abstract]   [Full Text] [Related]  

  • 19. Healthcare-associated
    Manea E; Jipa R; Milea A; Roman A; Neagu G; Hristea A
    Rom J Intern Med; 2021 Dec; 59(4):409-415. PubMed ID: 34053203
    [No Abstract]   [Full Text] [Related]  

  • 20. Updates in the epidemiology and management of candidemia and
    Falcone M; Tiseo G; Venditti M; Menichetti F
    Expert Rev Anti Infect Ther; 2019 May; 17(5):375-382. PubMed ID: 30982376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.